Press release
Global Small interfering RNA (siRNA) Therapeutics Market size, Industry Analysis, Share, Growth, Trends, Forecast 2017 - 2025
The objective of this report is to define, describe, and forecast the market on the basis of type, application, medical condition, and region. It provides detailed information regarding the major factors influencing the growth of the market. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, and financials.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1380633
Small interfering RNA (siRNA) is a type of genetic medicine, which has potential to silence or knock down any over-expressed gene in a disease. It is also called short interfering RNA. These RNAs are widely used to evaluate the specific contribution of genes to a variety of cellular phenotypes including apoptosis, insulin signaling, cytokinesis, and cell differentiation. They are employed to recognize novel pathways and have a meaningful impact in validating targets for several diseases (such as AIDS, cancer, and hepatitis) and cellular processes. The mechanism of action of siRNA involves its introduction into a cell. The sequence of siRNA is designed in such a way that it matches with a short area of the targeted gene. Small interfering RNA is processed by a cell’s own enzymes to abolish mRNA of the target gene, thereby preventing the over-expression of the disease-causing gene. It is based on natural response of cells when they detect genetic abnormality or infection. It has certain advantages over different types of therapies available currently, for example, target-specificity, reduced secondary effects, and high specificity. The pre-clinical development of small interfering RNA compound is of shorter duration (around 15 to 24 months) than that of monoclonal antibodies (around 27 to 50 months) or other traditional small molecules (around 42 to 66 months). This shortening of the pre-clinical stage is attributable to the rational design of RNAs. This design comprises mathematical algorithms assembled in software in order to select the most suitable RNA sequence to silence a specific gene target. They usually act longer than other traditional medicines.
The small interfering RNA (siRNA) therapeutics market is expected to expand significantly during the forecast period, as only a few products are currently available in the market. For example, Britena is a product approved for skin de-pigmentation. Most of the small interfering RNA therapeutics is currently under clinical development. It would be marketed in the next few years. There exist more than 15 companies developing over 85 small interfering RNA therapies. Small interfering RNA is being studied for various disease areas. However, most of the studies are focused on the oncology area with 27 siRNA therapies under development by major pharma companies, followed by 14 therapies for infectious diseases and eight therapies for ophthalmology. Two of the most popular methods of delivering siRNA therapies are liposome-based systems and nanoparticle-based systems. Liposome-based systems are associated with liver-targeted pharmacokinetics, a phenomenon that restricts the therapeutic potential of siRNA therapies to other common diseases of the liver such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.
View Report @ https://www.marketresearchreports.biz/reports/1380633/small-interfering-rna-sirna-therapeutics-market-research-reports
In terms of geography, the global small interfering RNA (siRNA) therapeutics market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the market, followed by Europe. This can be attributed to the large number of ongoing clinical trials, increase in the expenditure on research and development, and availability of developed health care infrastructure in North America. Asia Pacific is an emerging market for siRNA therapeutics, due to the developing health care infrastructure and rising government expenditure on the health care industry in the region. On the other hand, lack of developed health care infrastructure and limited research and development activities in Middle East & Africa restrain the siRNA therapeutics market in the region.
Major players operating in the global small interfering RNA (siRNA) therapeutics market are GE Dharmacon, OPKO Health, Inc., Alnylam Pharmaceuticals, Arrowhead Research Corp, Sanofi Genzyme, Genecon Biotechnologies Co., Ltd., Arbutus Biopharma Corp, Silence Therapeutics AG, and Sylentis S.A.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request for Enquiry @ https://www.marketresearchreports.biz/sample/enquiry/1380633
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Check Discount @ https://www.marketresearchreports.biz/sample/checkdiscount/1380633
Highlights of the report:
A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact us
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Small interfering RNA (siRNA) Therapeutics Market size, Industry Analysis, Share, Growth, Trends, Forecast 2017 - 2025 here
News-ID: 828193 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
